Abstract
Disintegrin variants and pharmaceutical uses thereof are disclosed. The disintegrin variant includes an isolated polypeptide that has integrin .alpha.v.beta.3 receptor-antagonist activity and substantially reduced integrin .alpha.llb.beta.3 and/or .alpha.5.beta.1 receptor-blocking activity as compared to a wild-type disintegrin.
| Translated title of the contribution | 去整合蛋白變異體及其醫藥用途 |
|---|---|
| Original language | English |
| Patent number | EP 2124548 |
| Publication status | Published - 2009 Dec 2 |
Fingerprint
Dive into the research topics of 'DISINTEGRIN VARIANTS AND PHARMACEUTICAL USES THEREOF'. Together they form a unique fingerprint.Cite this
- APA
- Author
- BIBTEX
- Harvard
- Standard
- RIS
- Vancouver